A randomized,controlled clinical trial on imipenem versus meropenem for the treatment of spontaneous bacterical peritonitis in liver cirrhosis patients.
- VernacularTitle:亚胺培南与美罗培南治疗肝硬化自发性细菌性腹膜炎临床对照研究
- Author:
Keping JI
;
Jun LI
;
Yuhua HAN
;
Hui SU
- Publication Type:Journal Article
- Keywords:
imipenem;
meropenem;
liver cirrhosis;
spontaneous bacterical peritonitis
- From:
Chinese Journal of Practical Internal Medicine
2001;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).Conclusion Imipenem and meropenem is effective and safe for the treatment of bacterial infection in spontaneous bacterical peritonitis patients.The average time of abatement of fever and treatment time in imipenem groups was shorter than than of meropenem groups.
